CR20160263A - Sistema multiparticulado para administrar drogas - Google Patents

Sistema multiparticulado para administrar drogas

Info

Publication number
CR20160263A
CR20160263A CR20160263A CR20160263A CR20160263A CR 20160263 A CR20160263 A CR 20160263A CR 20160263 A CR20160263 A CR 20160263A CR 20160263 A CR20160263 A CR 20160263A CR 20160263 A CR20160263 A CR 20160263A
Authority
CR
Costa Rica
Prior art keywords
multiparticulated
drugs
manage
manage drugs
capsules
Prior art date
Application number
CR20160263A
Other languages
English (en)
Inventor
Gonzaléz Roberto Carlos Bravo
Martin Kuentz
Felipe José Oliveira Varum
Kruif Jan Kendall De
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of CR20160263A publication Critical patent/CR20160263A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sistema multiparticulado para administrar drogas. Proceso para prepararlo. Cápsulas que han sido rellenadas con él.
CR20160263A 2013-11-13 2014-11-13 Sistema multiparticulado para administrar drogas CR20160263A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13192657 2013-11-13
EP14157427 2014-03-03
PCT/EP2014/074501 WO2015071366A1 (en) 2013-11-13 2014-11-13 Multi-particulate drug delivery system

Publications (1)

Publication Number Publication Date
CR20160263A true CR20160263A (es) 2017-04-05

Family

ID=51900424

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160263A CR20160263A (es) 2013-11-13 2014-11-13 Sistema multiparticulado para administrar drogas

Country Status (19)

Country Link
US (1) US20160287521A1 (es)
EP (1) EP3068381B1 (es)
JP (2) JP2016537352A (es)
KR (1) KR20160085269A (es)
CN (1) CN105899197A (es)
AU (1) AU2014350208B2 (es)
CA (1) CA2930277A1 (es)
CL (1) CL2016001148A1 (es)
CR (1) CR20160263A (es)
CU (1) CU20160069A7 (es)
EA (1) EA201600387A1 (es)
HK (1) HK1224219A1 (es)
MD (1) MD20160061A2 (es)
MX (1) MX2016006275A (es)
NZ (1) NZ720512A (es)
PE (1) PE20160850A1 (es)
PH (1) PH12016500847A1 (es)
TN (1) TN2016000160A1 (es)
WO (1) WO2015071366A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019072877A1 (en) 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
MX2020009824A (es) 2018-07-25 2021-01-15 Alteogen Inc Nuevas variantes de hialuronidasa y composicion farmaceutica que comprende la misma.
KR102154565B1 (ko) * 2018-11-13 2020-09-10 한국화학연구원 천연 오일을 함유하는 미세캡슐 및 이의 제조방법
CN112203642B (zh) 2019-03-25 2025-03-07 阿特根公司 用于皮下注射的包含人透明质酸酶ph20变体和药物的药物组合物
TW202615652A (zh) 2020-01-23 2026-04-16 南韓商阿特根公司 新穎的具有改善的穩定性的玻尿酸酶變異體及含有其的醫藥組合物
CN111388759B (zh) * 2020-04-28 2021-09-07 四川大学 一种骨水泥复合材料及其制备方法
WO2022031093A1 (ko) 2020-08-07 2022-02-10 (주)알테오젠 재조합 히알루로니다제의 생산 방법
JPWO2024101250A1 (es) * 2022-11-11 2024-05-16
KR102847026B1 (ko) * 2023-08-25 2025-08-18 에바바이오 주식회사 프릴링 방법을 적용하여 제조한 다중소포성 리포좀의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657653B2 (ja) * 1985-08-23 1994-08-03 藤沢薬品工業株式会社 油性懸濁型直腸注入剤
DK0531497T3 (da) * 1991-04-02 1998-03-23 Biotech Australia Pty Ltd Orale indgivelsessystemer til mikropartikler
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
FR2754177B1 (fr) * 1996-10-07 1999-08-06 Sanofi Sa Microspheres pharmaceutiques d'acide valproique pour administration orale
EE200100660A (et) * 1999-06-07 2003-04-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP4046313B2 (ja) * 2001-01-12 2008-02-13 株式会社資生堂 油中水型乳化組成物およびこれを用いた乳化化粧料
US7993749B2 (en) * 2005-12-16 2011-08-09 University Of Kansas Nanoparticles comprising a nanoparticle template and a polymer shell having an amide side chain, and method of making thereof
MX2008007697A (es) * 2005-12-16 2008-09-26 Univ Kansas Nanocumulos para la distribucion de farmacos.
PT103476B (pt) * 2006-05-10 2008-09-19 Univ De Coimbra Processo de produção e isolamento de micro- e nanopartículas poliméricas contendo macromoléculas de natureza hidrofílica e termolábil
JP5526033B2 (ja) * 2007-11-14 2014-06-18 ザ ユニバーシティ オブ クィーンズランド 微粒子製造装置および微粒子製造方法
EP2111854A1 (en) 2008-04-22 2009-10-28 Lek Pharmaceuticals D.D. Self-microemulsifying systems incorporated into liquid core microcapsules

Also Published As

Publication number Publication date
MX2016006275A (es) 2017-01-05
HK1224219A1 (zh) 2017-08-18
CL2016001148A1 (es) 2016-11-25
WO2015071366A1 (en) 2015-05-21
EP3068381B1 (en) 2019-09-11
AU2014350208B2 (en) 2017-09-07
JP2016537352A (ja) 2016-12-01
CA2930277A1 (en) 2015-05-21
PE20160850A1 (es) 2016-09-23
JP2019112413A (ja) 2019-07-11
AU2014350208A1 (en) 2016-06-16
MD20160061A2 (ro) 2016-10-31
TN2016000160A1 (en) 2017-10-06
CU20160069A7 (es) 2016-10-28
PH12016500847A1 (en) 2016-06-20
CN105899197A (zh) 2016-08-24
US20160287521A1 (en) 2016-10-06
EA201600387A1 (ru) 2016-08-31
KR20160085269A (ko) 2016-07-15
EP3068381A1 (en) 2016-09-21
NZ720512A (en) 2018-01-26

Similar Documents

Publication Publication Date Title
EP4223334B1 (en) DRUG ADMINISTRATION DEVICE
CU20160069A7 (es) Sistema multiparticulado para administrar drogas
IL245390B (en) Infusion system for preventing mischanneling of multiple medicaments
BR112015020743A2 (pt) cápsula de dose individual e sistema.
EP2968993A4 (en) MANIPULATION-SAFE PHARMACEUTICAL FORMULATIONS
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
DK3380146T3 (da) Medikamentadministrationsanordning
IL284999A (en) Identification of the patient's response to administration of a S1P receptor modulator
CL2014000864S1 (es) Envase de medicamento
CL2014000866S1 (es) Envase de medicamento
DK3357522T3 (da) Coatet medicinsk genstand til lægemiddelsfrigivelse
ZA201507576B (en) Pharmaceutical combination drug
DK3021911T3 (da) Anordning til indgivelse af lægemidler
IL248962A0 (en) Device and method for administering drugs to the brain
DK3041546T3 (da) Indretning til en lægemiddeladministrationsanordning
DK2964193T3 (da) Lægemidler til oral indgivelse
PL2968351T3 (pl) Preparaty dawkowania modulatora receptora opioidowego
IL245705B (en) Pharmaceutical dosage forms
LT3046537T (lt) Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui
DK3099357T3 (da) Medikamentadministrationsanordning
HRP20171888T1 (hr) Farmaceutski pripravci
UA28330S (uk) Капсула для лікарського засобу
UA28963S (uk) Пляшечка на ліки
UA28964S (uk) Пляшечка на ліки